MktsMarkets

Tonix Pharmaceuticals Holding Corp.
NASDAQ: TNXPKey statistics
TNXP News
Stories mentioning TNXP from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 6,878 | 5,390 | 3,290 | 1,998 | 2,429 | 2,582 | 2,822 | 2,208 |
| Cost of Goods Sold | 1,578 | 1,058 | 1,367 | 3,272 | 943.00 | 1,183 | 1,555 | 3,367 |
| Gross Profit | 5,300 | 4,332 | 1,923 | (1,274) | 1,486 | 1,399 | 1,267 | (1,159) |
| Operating Expenses | ||||||||
| Research & Development | 18,213 | 16,941 | 9,289 | 10,820 | 7,436 | 8,297 | 9,114 | 9,698 |
| Sales General & Admin | 28,624 | 35,677 | 25,701 | 16,202 | 10,104 | 15,582 | 7,707 | 7,502 |
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | (41,537) | (48,286) | (33,067) | (28,296) | (16,054) | (22,480) | (15,554) | (77,316) |
| Interest Income | 1,346 | 1,231 | 394.00 | 18.00 | ||||
| Interest Expense | ||||||||
| Other Expense | (3.00) | (578.00) | (1,156) | (1,955) | 394.00 | 376.00 | (44.00) | (606.00) |
| Pretax Income | ||||||||
| Tax Provision | ||||||||
| Net Income (Loss) | (40,194) | (46,910) | (32,010) | (28,272) | (16,829) | (22,108) | (14,213) | (78,776) |
| Earnings Per Share (Basic) | (2.93) | (5.51) | (3.59) | (3.86) | (2.84) | (30.04) | (22.68) | (1,921) |
| Earnings Per Share (Diluted) | (2.93) | (5.51) | (3.59) | (3.86) | (2.84) | (30.04) | (22.68) | (1,921) |
| Weighted Average Shares Outstanding (Basic) | 13,707 | 8,511 | 8,923 | 7,327 | 5,927 | 736.00 | 627.00 | 41.00 |
| Weighted Average Shares Outstanding (Diluted) | 13,707 | 8,511 | 8,923 | 7,327 | 5,927 | 736.00 | 627.00 | 41.00 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About TNXP
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) is a stock listed on the Nasdaq Stock Market under the ticker symbol TNXP. It last traded at $3.01 (Nov 13, 2026, 4:00 PM ET), down 7.1% on the day. That gives Tonix Pharmaceuticals a market capitalisation of $63.0M.
Over the past 52 weeks TNXP has traded between $3.21 and $20.56.
Revenue for the quarter ended Mar 31, 2026 was $6.9M; a net loss of $40.2M. Revenue was up 183% from $2.4M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $6.9M | -$40.2M | -584.4% |
| Dec 31, 2025 | $5.4M | -$46.9M | -870.3% |
| Sep 30, 2025 | $3.3M | -$32.0M | -972.9% |
| Jun 30, 2025 | $2.0M | -$28.3M | -1415.0% |
From Tonix Pharmaceuticals’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…